News & Events

  • February 15, 2013

    Atlas Financial Holdings, Inc. announced the closing of its initial public offering; 1,500,000 shares were sold by AFH and 2,625,000 shares were sold on behalf of selling shareholders. Total proceeds raised in the offering were $23,517,000. EG&S acted as counsel to Atlas.

  • February 15, 2013

    Nautilus Marine Acquisition Corp. (NASDAQ:NMAR) announced the completion of its acquisition of Assetplus Limited, a maritime energy services company controlling an initial fleet of vessels consisting of two platform supply vessels and two oil spill response vessels, as well as six binding time charter contracts with Brazilian oil major Petróleo Brasileiro S.A.  In connection therewith, Nautilus completed its self-tender offer for up to 4,137,300 shares of its common stock at a price of $10.10 per share. EG&S acted as counsel to Nautilus.

  • February 14, 2013

    Desert Gateway, Inc. announced the closing of their PIPE offering in the amount of $10,000,000. EG&S acted as counsel to the Investor.

  • February 11, 2013

    Opexa Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $3,250,002.  EG&S acted as counsel to the Placement Agent.
     

  • February 05, 2013

    ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $729,998.  EG&S acted as counsel to the Placement Agent.

  • January 31, 2013

    Morria Biopharmaceuticals PLC announced the closing of their Registered Direct offering in the amount of $10,000,000.  EG&S acted as counsel to the Placement Agent.
     

  • January 30, 2013

    Arrowhead Research Corp. announced the closing of their Confidentially Marketed Public offering in the amount of $1,250,002.  EG&S acted as counsel to the Placement Agent.

  • January 29, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited by the Inter American Development Bank and Multilateral Investment Fund to participate in their workshop “Crowdfunding: Financing Ideas, Entrepreneurs and Institutions The Market in Latin America and the Caribbean.” Mr. Ellenoff was part of two different panels: Discussion of Regulatory Aspects and Business Models Emerging due to the JOBS Act and Crowdfunding with Financial Returns.

  • January 24, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited by Harvard Business School Association of Boston to participate in their HBSAB 2013 New Venture Program (NVP) to discuss the viability of the emerging crowdfunding industry.

  • January 24, 2013

    ARCA biopharma, Inc. announced the closing of their PIPE offering in the amount of $499,999. EG&S acted as counsel to the Placement Agent.
     

  • January 14, 2013

    Excel Corporation (OTC Bulletin Board: EXCC) has announced the acquisition of startup credit card merchant acquiring company, Excel Business Solutions Inc. As a wholly owned subsidiary of Excel Corp., Excel Business Solutions intends to provide credit and debit card processing services for merchants in a variety of industries. Approximately 50% of the issued and outstanding shares of Excel Corporation will be held by the former stockholders of Excel Business Solutions Inc. EG&S acted as counsel to Excel Business Solutions Inc.

  • January 11, 2013

    22nd Century Group, Inc. announced the closing of their Registered Direct offering in the amount of $2,500,000.  EG&S acted as counsel to the Investor.

  • January 09, 2013

    Douglas S. Ellenoff, a member of the Firm, participated in "Crowdfund Texas: Impact of the JOBS Act on Texas Investors and Start-ups" in Austin, Texas on January 8, 2013.  It was a premiere industry conference that brought together Texas investors, start-ups, incubators, accelerators, and academic leaders in entrepreneurship for an intensive day of interactive educational sessions from leading thought leaders.  Mr. Ellenoff was invited to speak on several panels as well as one exclusively for the media.

    Click here to view the media panel
     

  • December 31, 2012

    DARA BioSciences Inc. announced the closing of their Registered Direct offering in the amount of $2,800,000.  EG&S acted as counsel to the Investor.

  • December 28, 2012

    SG Blocks, Inc. announced the closing of their PIPE offering in the amount of $1,000,000.  EG&S acted as counsel to the Investor.

  • December 28, 2012

    Brazahav Resources, Inc. closed a $5,000,000 loan agreement with Freepoint Metals & Concentrates LLC, and completed the initial takedown of $2,500,000.  EG&S acted as counsel to Brazahav Resources. 

  • December 26, 2012

    Netlist, Inc. announced the closing of their Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.

  • December 21, 2012

    Chart Acquisition Corp. (Nasdaq:CACGU) announced the closing of their SPAC IPO in the amount of $75,000,000.  EG&S acted as counsel to Chart.

  • December 17, 2012

    Oncosec Medical Inc. announced the closing of their Registered Direct offering in the amount of $7,200,000.  EG&S acted as counsel to the Placement Agent.

  • December 13, 2012

    Nautilus Marine Acquisition Corp. has commenced a Tender Offer for up to 4,137,300 Common Shares, at $10.10 per share, for an aggregate purchase price of $41,786,730, in connection with Nautilus’ acquisition of Assetplus Limited. The Tender Offer commenced on December 7, 2012 and is scheduled to expire, unless extended, on Monday, January 7, 2013.   We acted as counsel to Nautilus during their initial public offering, the tender offer and continue as their counsel.

  • December 12, 2012

    Generex Biotechnology Corporation announced the closing of their Registered Direct offering in the amount of $750,000.  EG&S acted as counsel to the Investor.

  • December 11, 2012

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for 2012.

    Click here to view the rankings

  • December 07, 2012

    Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $10,500,000.  EG&S acted as counsel to the Placement Agent.

  • December 04, 2012

    Rexahn Pharmaceuticals, Inc. announced the closing of their Underwritten offering in the amount of $7,260,000.  EG&S acted as counsel to the Underwriter.

  • December 03, 2012

    BioDelivery Sciences International, Inc. closed a $40 million registered direct offering to institutional investors of common stock and preferred stock. William Blair and Company, L.L.C acted as sole lead placement agent, and JMP Securities LLC and Roth Capital Partners, LLC acted as co-placement agents. EG&S acted as counsel to BioDelivery Sciences International, Inc.